Sonoma Biotherapeutics

Sonoma Biotherapeutics is a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, including a lead candidate for rheumatoid arthritis, with a partnership with Regeneron and a technology evaluation agreement with Cellares.

Company Facts

• Headquarters: South San Francisco, United States
• Founded: 2019
• Type: scaleup
• Website: https://www.sonomabio.com
• Industries: Biopharmaceuticals, Cell Therapy, Autoimmune Disease